Status:
UNKNOWN
I-gel vs Ambu AuraGain in Laparoscopic Gynecological Surgery
Lead Sponsor:
Dokuz Eylul University
Conditions:
Airway Morbidity
Anesthesia
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
To compare the effects of i-gel and Ambu AuraGain on ventilation parameters and surgical view during Trendelenburg position laparoscopic gynecological surgery in cases administered positive pressure v...
Detailed Description
Prospective, multicenter, randomized and double-blind study, aged from 18 to 65 years undergoing elective laparoscopic gynecological surgery. The patients are randomly assigned to 2 groups: Group i-...
Eligibility Criteria
Inclusion
- ASA classification I-II
- Between 18-65 years
- Undergoing elective laparoscopic gynecological surgery
Exclusion
- Those with any neck or upper respiratory tract pathology
- Those at risk of gastric content regurgitation/aspiration (previous upper GIS surgery, known hiatus hernia, gastroesophageal reflux, history of peptic ulcers, full stomach, pregnancy)
- Those with low pulmonary compliance or high airway resistance (chronic pulmonary diseases)
- Obese patients (BMI \>35)
- Those with throat pain, dysphagia and dysphonia
- Those with possible or previous difficult airway
- Those with operations planned for longer than 4 hours
- Conversion to laparotomy
- Neuromuscular blocking agent used
Key Trial Info
Start Date :
November 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT03760692
Start Date
November 1 2018
End Date
December 1 2024
Last Update
March 28 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Sureste University Hospital, Department of Anesthesiology and Critical Care
Madrid, Spain
2
Dokuz Eylul University, School of Medicine, Department of Anesthesiology and Intensive Care
Izmir, Turkey (Türkiye)